Meta-Analysis
Copyright ©The Author(s) 2021.
World J Hepatol. Jul 27, 2021; 13(7): 815-829
Published online Jul 27, 2021. doi: 10.4254/wjh.v13.i7.815
Table 1 Search strategy
Search strategy
Medline[(intragastric OR bariatric endoscopy OR balloon OR balloons OR bubble OR bubbles OR gastric balloon OR balloons)] AND [(mafld OR non alcoholic fatty liver disease OR nafld OR fatty liver OR nonalcoholic steatohepatitis OR nash OR nonalcoholic steatohepatitis OR alanine transaminase OR aspartate aminotransferase OR gamma-glutamyltransferase OR alkaline phosphatase OR fatty liver OR steatohepatitis OR steatohepatitis OR steatosis of liver OR visceral steatosis OR visceral]
MEDLINE, Embase, Cochrane, LILACS[(intragastric OR balloon)] AND [(fatty liver)]
Grey literature[(intragastric OR balloon)] AND [(fatty liver)]
  • Citation: de Freitas Júnior JR, Ribeiro IB, de Moura DTH, Sagae VMT, de Souza GMV, de Oliveira GHP, Sánchez-Luna SA, de Souza TF, de Moura ETH, de Oliveira CPMS, Bernardo WM, de Moura EGH. Effects of intragastric balloon placement in metabolic dysfunction-associated fatty liver disease: A systematic review and meta-analysis. World J Hepatol 2021; 13(7): 815-829
  • URL: https://www.wjgnet.com/1948-5182/full/v13/i7/815.htm
  • DOI: https://dx.doi.org/10.4254/wjh.v13.i7.815